Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026)
Genmab A (GMAB) posted Amortizatization of Intangibles of $13.0 million for Q1 2026, up 18.18% on a QoQ basis from $11.0 million in Q3 2025, and up 225.0% year-over-year from $4.0 million in Q1 2025.
Genmab A (GMAB) Amortizatization of Intangibles (2024 - 2026) Analysis & Trends
Genmab A's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $13.0 million for Q1 2026.
- Quarterly Amortizatization of Intangibles rose 225.0% year-over-year to $13.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.0 million (up 105.88% YoY) and the FY2025 annual result came in at $16.0 million, up 45.45% from the prior year.
- Amortizatization of Intangibles was $13.0 million for Q1 2026 at Genmab A, up from $11.0 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $13.0 million in Q1 2026 and bottomed at $2.0 million in Q1 2024.
- A 3-year average of $6.9 million and a median of $7.0 million in 2024 frame the typical range for Amortizatization of Intangibles.
- Annual changes were most pronounced in 2025 — Amortizatization of Intangibles jumped 57.14% — and 2026, when it jumped 225.0%.
- Genmab A's Amortizatization of Intangibles stood at $7.0 million in 2024, then soared by 57.14% to $11.0 million in 2025, then rose by 18.18% to $13.0 million in 2026.
- Business Quant data shows GMAB's Amortizatization of Intangibles at $13.0 million in Q1 2026, $11.0 million in Q3 2025, and $7.0 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Genmab A | 1.87 Bn | 349.77 Mn | 831.00 Mn | 13.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.00 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Sep 30, 2025 | 11.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Mar 31, 2024 | 2.00 Mn |